Literature DB >> 33320243

Maximizing the Uptake of a COVID-19 Vaccine in People With Severe Mental Illness: A Public Health Priority.

Nicola Warren1,2, Steve Kisely3, Dan Siskind1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33320243     DOI： 10.1001/jamapsychiatry.2020.4396

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  18 in total

1.  COVID-19 vaccination uptake in people with severe mental illness: a UK-based cohort study.

Authors:  Lamiece Hassan; Chelsea Sawyer; Niels Peek; Karina Lovell; Andre F Carvalho; Marco Solmi; George Tilston; Matthew Sperrin; Joseph Firth
Journal:  World Psychiatry       Date:  2022-02       Impact factor: 49.548

2.  COVID-19 Booster Vaccination Among Individuals With Schizophrenia in Israel.

Authors:  Dana Tzur Bitan; Khalaf Kridin; Noga Givon-Lavi; Israel Krieger; Ehud Kaliner; Arnon Dov Cohen; Orly Weinstein
Journal:  JAMA Psychiatry       Date:  2022-05-01       Impact factor: 25.911

3.  Editorial: Ensuring COVID-19 vaccine uptake by people with severe mental illness: a mental health nursing priority.

Authors:  Kim Usher
Journal:  Int J Ment Health Nurs       Date:  2021-05-07       Impact factor: 3.503

Review 4.  COVID-19 vaccination for people with severe mental illness: why, what, and how?

Authors:  Victor Mazereel; Kristof Van Assche; Johan Detraux; Marc De Hert
Journal:  Lancet Psychiatry       Date:  2021-02-03       Impact factor: 27.083

5.  Severe mental illness and European COVID-19 vaccination strategies.

Authors:  Livia J De Picker; Marisa Casanova Dias; Michael E Benros; Benedetta Vai; Igor Branchi; Francesco Benedetti; Alessandra Borsini; Juan Carlos Leza; Hilkka Kärkkäinen; Miia Männikkö; Carmine M Pariante; Ekin Sönmez Güngör; Anna Szczegielniak; Ryad Tamouza; Afra van der Markt; Paolo Fusar-Poli; Julian Beezhold; Marion Leboyer
Journal:  Lancet Psychiatry       Date:  2021-02-17       Impact factor: 27.083

6.  Further Adaptations and Reflections by an Assertive Community Treatment Team to Serve Clients with Severe Mental Illness during COVID-19.

Authors:  Samuel Law; Iline Guan; Michaela Beder; Madeleine Ritts; Saadia Sediqzadah; Matthew Levy; Nicole Kirwan
Journal:  Community Ment Health J       Date:  2021-06-09

7.  The post COVID-19 healthcare landscape and the use of long-acting injectable antipsychotics for individuals with schizophrenia and bipolar I disorder: the importance of an integrated collaborative-care approach.

Authors:  Christoph U Correll; Craig Chepke; Paul Gionfriddo; Joe Parks; Phyllis Foxworth; Anirban Basu; Teri S Brister; Dawn Brown; Christopher Clarke; Youssef Hassoun
Journal:  BMC Psychiatry       Date:  2022-01-10       Impact factor: 3.630

8.  COVID-19 Vaccination Rates in a Cohort Study of Patients With Mental Illness in Residential and Community Care.

Authors:  Victor Mazereel; Tom Vanbrabant; Franciska Desplenter; Johan Detraux; Livia De Picker; Erik Thys; Ken Popelier; Marc De Hert
Journal:  Front Psychiatry       Date:  2021-12-16       Impact factor: 4.157

9.  Underlying factors in the willingness to receive and barriers to receiving the COVID-19 vaccine among residents in the UK and Nigeria: a qualitative study.

Authors:  Ifeanyichukwu Anthony Ogueji; Maia Makeda Okoloba
Journal:  Curr Psychol       Date:  2022-01-14

10.  Examining COVID-19 vaccine uptake and attitudes among 2SLGBTQ+ youth experiencing homelessness.

Authors:  Alex Abramovich; Nelson Pang; Sharumathy Kunasekaran; Amanda Moss; Tara Kiran; Andrew D Pinto
Journal:  BMC Public Health       Date:  2022-01-18       Impact factor: 3.295
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.